Rezapour Aziz, Nargesi Shahin, Mezginejad Fateme, Rashki Kemmak Asma, Bagherzadeh Rafat
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Iran J Public Health. 2021 Jan;50(1):35-45. doi: 10.18502/ijph.v50i1.5070.
Cancer is the third cause of death following cardiovascular disease and accidents, in Iran. The purpose of this study was to systematically review the economic burden of cancer studies in Iran.
This systematic review examined the types of direct medical and non-medical costs and indirect costs in cancer patients and includes studies in English and Persian that were reviewed in Scopus, Web of science, SID, Iranmedex, Magiran and databases of Medline, etc., from 1995-2019.
Twenty-one articles were included. Most studies have examined the direct costs of all types of cancers. The articles reviewed different types of cancer, such as prostate cancer (n=2), colorectal cancer (n=2), breast cancer (n=4), gastric cancer (n=2), oral and pharyngeal cancer (n=1), lung cancer (n=3), and blood cancer (n=4). The great number of studies were related to the gastrointestinal, breast and blood cancers. The gastrointestinal (gastric and colorectal) and breast cancer had the major economic burden than others.
It is necessary that special attention to patients, supportive measures to reduce the share of costs, and more budget allocation for prevention, screening and early detection being at priorities in the health system planning.
在伊朗,癌症是继心血管疾病和意外事故之后的第三大死因。本研究的目的是系统评价伊朗癌症研究的经济负担。
本系统评价考察了癌症患者的直接医疗和非医疗成本以及间接成本的类型,纳入了1995年至2019年期间在Scopus、科学网、伊朗科学数据库、伊朗医学数据库、伊朗医学索引以及Medline等数据库中检索到的英文和波斯文研究。
共纳入21篇文章。大多数研究考察了各类癌症的直接成本。这些文章涉及不同类型的癌症,如前列腺癌(n = 2)、结直肠癌(n = 2)、乳腺癌(n = 4)、胃癌(n = 2)、口腔和咽喉癌(n = 1)、肺癌(n = 3)以及血癌(n = 4)。大量研究与胃肠道癌、乳腺癌和血癌相关。胃肠道癌(胃癌和结直肠癌)和乳腺癌的经济负担比其他癌症更重。
在卫生系统规划中,有必要优先特别关注患者,采取支持措施以降低成本份额,并为预防、筛查和早期检测分配更多预算。